Catalyst Calendar - February 05, 2026 (Morning)

 ## Major Catalysts Mentioned **Aurora Cannabis** - Date: TBD - Why it matters: Aurora Cannabis reports increased revenue and free cash flow, indicating potential operational improvements and market confidence. - Stocks affected: **$ACB** **Marathon Petroleum** - Date: TBD - Why it matters: Price target raised to $198 from $183 at TD Cowen, reflecting bullish sentiment on the company's outlook and operational strength. - Stocks affected: **$MPC** **Bristol Myers** - Date: TBD - Why it matters: The company forecasts an upbeat 2026, particularly anticipating that the price cut on Eliquis will enhance profitability. - Stocks affected: **$BMY** **ScanSource** - Date: TBD - Why it matters: Earnings missed by $0.21, highlighting challenges in revenue performance and potentially impacting investor sentiment. - Stocks affected: **$SCSC** **Peloton** - Date: TBD - Why it matters: Peloton is losing money again as subscriptions continue to decline, raising concerns about long-term viability. - Stocks affected: **$PTON** ## Earnings on Deck - **$LITE** - Reports: TBD - Key watch: Growth metrics and outlook. - **$QCOM** - Reports: TBD - Key watch: Guidance on memory chip shortages. ## Economic Events - **US weekly jobless claims** - Date: TBD - Expected impact: Increased claims could signal economic weakening. ## Regulatory & Legal - No relevant upcoming regulatory events mentioned. ## What's NOT Dated But Worth Tracking - **Investor attitudes towards AI and tech stocks**: With ongoing discussions about AI spending and its impact on companies like Alphabet, monitoring the market's response is crucial. - **Crypto market developments**: The evolving landscape of cryptocurrency trading and regulation is significant, especially with potential implications for major companies. ## Highest Conviction Catalyst - What: **Bristol Myers' 2026 Outlook** - When: TBD - Why it matters: The company's positive forecast, particularly regarding the expected profitability from the Eliquis price cut, could boost investor confidence and stock performance. Analysts will be watching closely to see how this plays out against the backdrop of competitive pressures in the pharmaceutical sector. - Trade idea: Consider bullish positions on **$BMY** given the optimistic outlook.